11 Oorjita research notes discuss Dr. Reddy's Laboratories.
On February 25, the US Department of Commerce announced preliminary countervailing duties (CVD) of approximately 126% on Indian solar module imports.
Despite flat index performance, more stocks declined (1672) than advanced (1494), indicating weak internal market strength. This suggests the market move was concentrated in a few heavyweight stocks.
Mankind Pharma is India’s 4th largest pharmaceutical company by domestic market value, with a diversified presence across prescription pharmaceuticals, consumer healthcare/OTC, and exports.
Sustainability above 26,150 levels and volume confirmation will determine whether yesterday's breakout has conviction or if profit-booking emerges at psychological 26,200+ zones.
